Sales of respiratory medications key to predicting disease mortality, UK study finds

The value of integrating national longitudinal shopping data into respiratory disease forecasting models.

AbbVie’s full year 2023 sees 6.4% net revenue drop

Share this article The immunology portfolio of AbbVie, which faced stiff competition from Humira biosimilars, saw revenues decrease by 9.6% to $26.14bn. Credit: Valery Zankovych

February 5, 2024

Trends in antibiotic usage among inpatients in South America during COVID-19 pandemic

Researchers evaluate how the COVID-19 pandemic impacted antibiotic use in healthcare facilities throughout South America.

July 12, 2023

Can a validated deep learning model facilitate the diagnosis and management of adolescent idiopathic scoliosis?

Researchers evaluated the ability of a smartphone application based on a deep learning model to identify adolescent idiopathic scoliosis.

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.